Impact of steroids on hepatitis C virus replication in vivo and in vitro

Annals of the New York Academy of Sciences

Volumn 1110, Issue , 2007, Pages 439-447

  Henry, Scot D ^a   Metselaar, Herold J ^a   Van Dijck, Jeroen ^a   Tilanus, Hugo W ^a   Van Der Laan, Luc J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Corticosteroids; HCV; Prednisolone; Recurrence; Replicon

Indexed keywords

CELL PROTEIN; DEXAMETHASONE; LUCIFERASE; PREDNISOLONE; STEROID;

CELL PROLIFERATION; CONFERENCE PAPER; DISEASE SEVERITY; GENE EXPRESSION; HEPATITIS; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; VIRUS LOAD; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 35748950134     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1423.046     Document Type: Conference Paper

References (31)

1. STARZL, T.E., T.L. MARCHIORO, K.A. PORTER, et al. 1967. Homotransplantation of the liver. Transplantation 5(Suppl.): 790-803.
2. EVERSON, G.T. 2002. Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl. 8: S19-S27.
3. CALLEJA, J.L., A. ALBILLOS, G. CACHO, et al. 1996. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J. Hepatol. 24: 308-312.
4. FONG, T.L., B. VALINLUCK, S. GOVINDARAJAN, et al. 1994. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 107: 196-199.
5. MAGRIN, S., A. CRAXI, C. FABIANO, et al. 1994. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 19: 273-279.
6. GANE, E.J., N.V. NAOUMOV, K.P. QIAN, et al. 1996. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110: 167-177.
7. GANE, E.J., B.C. PORTMANN, N.V. NAOUMOV, et al. 1996. Long-term outcome of hepatitis C infection after liver transplantation. New Engl. J. Med. 334: 815-820.
8. FUKUMOTO, T., T. BERG, Y. KU, et al. 1996.Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology 24: 1351-1354.
9. BOOR, P.P., H.J. METSELAAR, S. MANCHAM, et al. 2006. Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am. J. Transplant. 6: 2332-2341.
10. ROSEN, H.R., D.J. HINRICHS, D.R. GRETCH, et al. 1999. Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 117: 926-932.
11. PAPATHEODORIDIS, G.V., S.G. BARTON, D. ANDREW, et al. 1999. Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens. Gut 45: 427-434.
12. PAPATHEODORIDIS, G.V., S. DAVIES, A.P. DHILLON, et al. 2001. The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 72: 412-418.
13. FILIPPONI, F., F. CALLEA, M. SALIZZONI, et al. 2004. Double-blind comparison of hepatitis C histological recurrence rate in HCV+liver transplant recipients given basiliximab+steroids or basiliximab+placebo, in addition to cyclosporine and azathioprine. Transplantation 78: 1488-1495.
14. LLADO, L., X. XIOL, J. FIGUERAS, et al. 2006. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study. J. Hepatol. 44: 710-716.
15. KUO, A. & N.A. TERRAULT. 2006. Management of hepatitis C in liver transplant recipients. Am. J. Transplant. 6: 449-458.
16. BERENGUER, M., V. AGUILERA, M. PRIETO, et al. 2006. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression. J. Hepatol. 44: 717-722.
17. BRILLANTI, S., M. VIVARELLI, N. DE RUVO, et al. 2002. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl. 8: 884-888.
18. LAKE, J.R. 2003. The role of immunosuppression in recurrence of hepatitis C. Liver Transpl. 9: S63-S66.
19. EGHTESAD, B., J.J. FUNG, A.J. DEMETRIS, et al. 2005. Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl. 11: 1343-1352.
20. LOHMANN, V., F. KORNER, J. KOCH, et al. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
21. HENRY, S.D., H.J. METSELAAR, R.C. LONSDALE, et al. 2006. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin a and interferon-alpha. Gastroenterology 131: 1452-1462.
22. HENRY, S.D., P. VAN DER WEGEN, H.J. METSELAAR, et al. 2006. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol. Ther. 14: 485-493.
23. WINDISCH, M.P., M. FRESE, A. KAUL, et al. 2005. Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J. Virol. 79: 13778-13793.
24. AUWARDT, R.B., S.J. MUDGE, C.G. CHEN, et al. 1998. Regulation of nuclear factor kappaB by corticosteroids in rat mesangial cells. J. Am. Soc. Nephrol. 9: 1620-1628.
25. MIYAZAWA, K., A. MORI & H. OKUDAIRA. 1998. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by glucocorticoids. J. Biochem. 124: 1130-1137.
26. JOHN, M., S.J. HIRST, P.J. JOSE, et al. 1997. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J. Immunol. 158: 1841-1847.
27. RAY, A. & K.E. PREFONTAINE. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91: 752-756.
28. SHEPPARD, K.A., K.M. PHELPS, A.J. WILLIAMS, et al. 1998. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273: 29291-29294.
29. DE BOSSCHER, K., M.L. SCHMITZ, W. VANDEN BERGHE, et al. 1997. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 94: 13504-13509.
30. NISSEN, R.M. & K.R. YAMAMOTO. 2000. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Develop. 14: 2314-2329..
31. DEBOSSCHER, K., W. VANDENBERGHE, L. VERMEULEN, et al. 2000. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. USA 97: 3919-3924.